EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL
BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter... | September 17, 2022
United States Philippe Genereux Firas Zahr Konstantinosp Koulogiannis Megan Coylewright Paula Grayburn
Source: marketscreener.com